Profound Medical PROF Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Profound Medical's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
- Profound Medical (PROF) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$845K in Q1 2026.
- How has Profound Medical's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
- Profound Medical's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 998.9% year-over-year, from $94K to -$845K.